4.6 Article

Standardized Pomegranate (Pomella(R)) and Red Maple (Maplifa(R)) Extracts and Their Phenolics Protect Type I Collagen by the Inhibition of Matrix Metalloproteinases, Collagenase, and Collagen Cross-Linking

期刊

MOLECULES
卷 27, 期 22, 页码 -

出版社

MDPI
DOI: 10.3390/molecules27227919

关键词

pomegranate (Punica granatum); red maple (Acer rubrum); punicalagin; ginnalin A; collagenase; cross-linking; anti-skin-aging

资金

  1. Department of Education of Guangdong Province [2017KSYS010, 2019KZDZX2003]
  2. Jiangmen Program for Innovative Research Team [2018630100180019806]
  3. National Natural Science Foundation of China [81803390]
  4. IDeA NIH/NIGMS grant [P20GM12345]
  5. LBRN-INBRECOBRE Administrative Supplement Award from an IDeA NIH/NIGMS grant [3P20GM103424-18S1]
  6. Louisiana Board of Regents Support Fund [LEQSF (2021-24)-RD-A-22]

向作者/读者索取更多资源

Phenolics enriched pomegranate fruit (Pomella(R)) and red maple leaf (Maplifa(R)) extracts, along with their major phenolic constituents, demonstrate protective effects on skin collagen. Their synergistic collagenase inhibitory effects suggest potential as active ingredients in skincare products.
Phenolics enriched pomegranate fruit (Pomella(R)) and red maple leaf (Maplifa(R)) extracts and their major phenolic constituents have demonstrated beneficial skin effects through the protection of human skin keratinocytes from oxidative-stress-induced damage. However, their mechanisms of protection of cutaneous collagen are still unclear. Herein, the collagen protective effects of Pomella(R) and Maplifa(R), and their major bioactive phytochemicals, namely, punicalagin (PA) and ginnalin A (GA), respectively, were evaluated using enzymatic assays including collagenase, anti-glycation and cell-based models as well as computational methods. The importance of the modulatory effects was validated at the protein level for type I collagen and matrix metalloproteinases (MMPs) using human-skin-derived keratinocytes. The synergistic collagenase inhibitory effects upon combinations of Pomella(R) + Maplifa(R) and PA + GA at a combination ratio of 1:2 and 1:1, respectively, were evaluated using their combination index (CI; a well-established assessment of synergism). Pomella(R) (50-400 mu g/mL), Maplifa(R) (100-800 mu g/mL), PA (50-400 mu M), and GA (50-400 mu M) dose-dependently inhibited collagenase activity by 26.3-86.3%, 25.7-94.0%, 26.2-94.0%, and 12.0-98.0%, respectively. The CI of the anti-collagenase activity of Pomella(R) and Maplifa(R) ranged from 0.53-0.90, while that of PA and GA (12.5/12.5 and 25/25 mu M) ranged from 0.66 and 0.69, respectively, suggesting a synergistic inhibitory effect. Interestingly, in the cell-based assays by Western blotting, Pomella(R) and Maplifa(R) reduced the protein expression levels of collagen degradation enzymes (MMPs), while simultaneously increasing that of type I collagen in epidermoid carcinoma A431 cells. This is the first report to show that these extracts exert synergistic collagen protective effects. Taken together, these findings provide molecular insights into the usefulness of Pomella(R) and Maplifa(R) or their phenolics as bioactive ingredients for skin care products to slow down aging and enhance skin tone.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据